Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

Mizuho Securities analyst Salim Syed has assigned their bullish stance on BBIO stock, giving a Buy rating on November 25.Don't Miss our Black ...

The firm develops BBP-265, an oral small molecule transthyretin for the treatment of TTR amyloidosis, including cardiomyopathy and polyneuropathy manifestations; infigratinib, an oral FGFR1-3 ...

Using genetic tools, the scientists then blocked TYK2 in the mice with Alzheimer's. This resulted in a reduction in the ...

2024 年 12 月 6 日 - 8 日，欧洲肿瘤内科学会亚洲年会（ESMO Asia）将在新加坡盛大召开。本届会议将汇聚全球专家学者，集中展示和讨论肿瘤学领域的最新科学和临床进展，为肿瘤领域带来一场学术盛宴。此次会议中，「Dato-DXd ...

But this study found that the enzyme tyrosine kinase 2 (TYK2), which plays a central role in the immune system ... The ...

Immunome, Inc. (NASDAQ:IMNM – Get Free Report) gapped up prior to trading on Monday after an insider bought additional shares in the company. The stock had previously closed at $9.82, but opened at ...

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from ...